Unitaid

Nigeria carries the highest malaria burden globally, accounting for an estimated 27% of all malaria cases worldwide.

In Abuja, Janet Ginnard, Unitaid’s Director of Strategy, joined the Honorable Minister of Health and Social Welfare, Muhammad Ali Pate, alongside partners from the The Global Fund and RBM Partnership to End Malaria to discuss how stronger collaboration can support Nigeria’s malaria response.

The discussion focused on sustainable financing, local manufacturing, and ensuring effective tools reach the people who need them most.

As malaria challenges evolve, continued partnership and investment remain critical to turning innovation into impact at scale.

Lenacapavir could expand HIV prevention options globally, strengthening the range of tools available for people at risk.

The recent rollout in South Africa is an important milestone. It also reflects a broader reality in global health: innovation alone does not guarantee access.

Ensuring impact requires deliberate action to shape markets.

Market shaping addresses the barriers that can delay or limit access, including price, supply constraints, licensing arrangements, and the risks manufacturers face when entering lower-income markets. Without these measures, even highly effective innovations can take years to reach scale.

Through coordinated efforts, Unitaid and partners are supporting a pathway to generic lenacapavir at an expected price of 40 USD per person per year, helping move from breakthrough science to sustainable affordability. Access turns innovation into impact.

Extreme heat can degrade medicines, reduce their potency and compromise care before they reach patients. As temperatures rise, health products are increasingly exposed to conditions beyond their tested limits across supply chains, putting their safety and effectiveness at risk.

These impacts are most severe in low- and middle-income countries, where maintaining controlled storage and transport is often difficult. Strengthening access to climate-resilient, heat-stable products is essential to ensure lifesaving care remains safe, effective and accessible in a changing climate.

Learn more:https://unitaid.org/uploads/12858-Knowledge-Paper-Heat-Proofing-Health-Products-RGB14.pdf